<DOC>
	<DOCNO>NCT01261416</DOCNO>
	<brief_summary>The primary objective study determine pharmacokinetic profile load dose intravenous levetiracetam , give clinical reason , term late preterm infant seizures . Secondary objective evaluate safety efficacy levetiracetam term preterm infant seizure .</brief_summary>
	<brief_title>Pharmacokinetics Levetiracetam ( Keppra ) Neonates</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Gestational age ≥ 32 week Postnatal age ≤ 30 day Birth weight ≥ 2000 gram Admitted NICU Cincinnati Children 's Hospital Good Samaritan Hospital Clinical electrographic seizure etiology Seizures seizure prophylaxis require treatment levetiracetam Parental consent obtain Infants renal insufficiency indicate serum creatinine &gt; 2.0 time Infants previously receive levetiracetam Parents refuse consent Attending physician wish infant enrol study Infants currently receive investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Days</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>seizure</keyword>
	<keyword>epilepsy</keyword>
	<keyword>neonatal</keyword>
	<keyword>levetiracetam</keyword>
</DOC>